What is the recommended scoring system and treatment for thyroid storm?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Thyroid Storm Scoring and Treatment

Diagnostic Scoring Systems

The Burch-Wartofsky Point Scale is the recommended scoring system for diagnosing thyroid storm, which evaluates fever, cardiovascular effects, central nervous system manifestations, and gastrointestinal-hepatic dysfunction to stratify patients into categories of thyroid storm likelihood. 1, 2

  • An alternative diagnostic approach is Akamizu's diagnostic criteria, which can also be considered for thyroid storm diagnosis 1
  • Do not delay treatment while awaiting laboratory confirmation, as thyroid hormone levels do not differ between uncomplicated thyrotoxicosis and thyroid storm—the diagnosis is entirely clinical 3, 4
  • Mortality may rise significantly (up to 75%) with treatment delays, making immediate clinical recognition and intervention critical 3, 4

Key Clinical Features to Identify

  • Fever, tachycardia disproportionate to fever, altered mental status, gastrointestinal symptoms, and cardiac arrhythmias characterize thyroid storm 3
  • The mortality rate without treatment ranges from 80-100%, but drops to 10-50% with appropriate treatment 1, 4

Immediate Treatment Algorithm

Step 1: Stabilization and Hospitalization

  • Hospitalize all patients with thyroid storm; severe cases require ICU admission 5, 3
  • Immediately administer supplemental oxygen and position patient head-up to improve respiratory function 3
  • Establish continuous cardiac monitoring 5

Step 2: Block Thyroid Hormone Synthesis (First Medication)

Administer propylthiouracil (PTU) as the first-choice thionamide because it inhibits both thyroid hormone synthesis AND peripheral conversion of T4 to T3 5, 3, 6, 7

  • Initial dosing: 600-900 mg loading dose for severe cases, then 200-300 mg every 6-8 hours 7
  • Standard initial dose is 300 mg daily in divided doses; severe cases may require 400-900 mg daily 7
  • Methimazole can be used if PTU is unavailable, but lacks the peripheral conversion inhibition benefit 5

Step 3: Block Thyroid Hormone Release (1-2 Hours After Thionamides)

Administer saturated potassium iodide solution or sodium iodide 1-2 hours AFTER starting thionamides—never before, as this can worsen thyrotoxicosis 5, 3, 6

  • This critical timing prevents iodine from serving as substrate for new hormone synthesis 5

Step 4: Control Adrenergic Effects with Beta-Blockers

Propranolol is the preferred beta-blocker because it blocks peripheral T4 to T3 conversion in addition to controlling cardiovascular symptoms 5

  • Dosing: 60-80 mg orally every 4-6 hours 5
  • For hemodynamically unstable patients requiring vasopressor support, use esmolol instead due to its ultra-short half-life allowing rapid titration 5
  • Esmolol dosing: 500 mcg/kg IV loading dose over 1 minute, then maintenance infusion starting at 50 mcg/kg/min, titrating up to maximum 300 mcg/kg/min 5
  • If beta-blockers are contraindicated, use diltiazem 15-20 mg (0.25 mg/kg) IV over 2 minutes, then 5-15 mg/h maintenance infusion 5

Step 5: Reduce Peripheral T4 to T3 Conversion

Administer dexamethasone or another corticosteroid to reduce peripheral conversion of T4 to T3 and treat potential relative adrenal insufficiency 5, 3, 6

Step 6: Supportive Care

  • Administer antipyretics to control fever (avoid aspirin as it may increase free thyroid hormone) 5
  • Provide aggressive hydration 5
  • Identify and treat precipitating factors: infection, surgery, childbirth, trauma, diabetic ketoacidosis 5, 3

Critical Monitoring Requirements

  • Monitor for agranulocytosis with thionamide use—this is a life-threatening complication 5, 3, 6
  • Watch for cardiac complications including heart failure and arrhythmias 5, 3, 6
  • In patients on esmolol with vasopressor support, maintain continuous cardiac monitoring with serial blood pressure and heart rate every 5-15 minutes during titration 5
  • Monitor for hypotension, bradycardia, and hyperkalemia, particularly in patients with renal impairment 5

Post-Acute Phase Management

  • Monitor thyroid function every 2-3 weeks after initial stabilization 5, 3
  • Watch for transition to hypothyroidism, which commonly occurs after thyroid storm treatment 5, 3
  • Plan definitive treatment (continued medical therapy, thyroidectomy, or radioactive iodine ablation) after the acute crisis resolves 3
  • If medical treatment fails to produce clinical improvement within 12-24 hours, early thyroidectomy should be considered 4

Special Population Considerations

Pregnancy

  • Treatment protocol is similar to non-pregnant patients 5, 3, 6
  • Monitor fetal status continuously 5, 3, 6
  • Avoid delivery during thyroid storm unless absolutely necessary 5, 3, 6

Pediatric Patients

  • PTU is generally not recommended in pediatric patients except in rare instances where alternatives are inappropriate 7
  • For patients 6 years or older, initiate at 50 mg daily with careful upward titration based on TSH and free T4 levels 7

Geriatric Patients

  • Use cautious dose selection reflecting greater frequency of decreased hepatic, renal, or cardiac function 7
  • Thyrotoxic crisis occurs predominantly in the elderly with higher mortality risk 4

References

Research

Low cardiac output thyroid storm in a girl with Graves' disease.

Pediatrics international : official journal of the Japan Pediatric Society, 2016

Guideline

Thyroid Storm Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

[Thyroid storm--thyrotoxic crisis: an update].

Deutsche medizinische Wochenschrift (1946), 2008

Guideline

Thyroid Storm Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnóstico y Tratamiento de la Tormenta Tiroidea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.